Expression of Osteoprotegerin in Placenta and Its Association with Preeclampsia

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Shen, Pei ^a   Gong, Yunhui ^a   Wang, Tao ^a   Chen, Yueyue ^a   Jia, Jin ^a   Ni, Shanshan ^a   Zhou, Bin ^a   Song, Yapin ^a   Zhang, Lin ^a   Zhou, Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OSTEOPROTEGERIN;

ADIPOSE TISSUE; ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOTROPHOBLAST; DELIVERY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; OSTEOPROTEGERIN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER;

EID: 84865591565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044340     Document Type: Article

References (28)

1. Yücesoy G, Ozkan S, Bodur H, Bodur H, Tan T, et al. (2005) Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 273(1): 43-49.
2. Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, et al. (2008) Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci 15(4): 374-381.
3. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, et al. (2002) First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 87(4): 1563-1568.
4. Lockwood CJ, Yen CF, Basar M, Kayisli UA, Martel M, et al. (2008) Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 172(6): 1571-1579.
5. Brodszki J, Länne T, Laurini R, Strevens H, Wide-Swensson D, et al. (2008) Vascular mechanical properties and endothelial function in pre-eclampsia with special reference to bilateral uterine artery notch. Acta Obstet Gynecol Scand 87(2): 154-162.
6. Silasi M, Cohen B, Karumanchi SA, Rana S, (2010) Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 37(2): 239-53.
7. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R, (2010) Pre-eclampsia. Lancet 376(9741): 631-44.
8. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2): 309-319.
9. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is idenfical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95(7): 3597-3602.
10. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, et al. (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273(23): 14363-14367.
11. Price PA, June HH, Buckley JR, Williamson MK, (2001) Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol. 21(10): 1610-1616.
12. Kobayashi-Sakamoto M, Hirose K, Nishikata M, Isogai E, Chiba I, (2006) Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases. FEMS Microbiol Lett 264(2): 238-245.
13. Abedin M, Omland T, Ueland T, Khera A, Aukrust P, et al. (2007) Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol 99(4): 513-518.
14. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, et al. (2004) Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109(18): 2175-2180.
15. Yaturu S, Rains J, Jain SK, (2008) Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. Cytokine 44(1): 168-171.
16. Kim SM, Lee J, Ryu OH, Lee KW, Kim HY, et al. (2005) Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol(Oxf) 63(5): 594-598.
17. Shin JY, Shin YG, Chung CH, (2006) Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 29(7): 1664-1666.
18. Brändström H, Stiger F, Kahan T, Melhus H, Nyström F, et al. (2004) A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). Blood Pressure 13(3): 152-157.
19. Ziegler S, Kudlacek S, Luger A, Minar E, (2005) Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. Atherosclerosis 182(1): 175-180.
20. ACOG practice bulletin, (2002) Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 299(1): 159-167.
21. Tie Weiwei, Yu Haiyan, Chen Juan, Wang Xiaodong, Chen Weibo, et al. (2009) Expression of adiponectin receptors in placenta and their correlation with preeclampsia. Reprod Sci 16(7): 676-84.
22. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408.
23. Phillips TA, Ni J, Hunt JS, (2001) Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 22(8-9): 663-672.
24. Hong JS, Santolaya-Forgas J, Romero R, Gonçalves LF, Kim YM, et al. (2005) Maternal plasma osteoprotegerin concentration in normal pregnancy. Am J Obstet Gynecol, 193(3 Pt 2): 1011-1015.
25. Uemura H, Yasui T, Kiyokawa M, Kuwahara A, Ikawa H, et al. (2002) Serum osteoprotegerin/osteoclasto genesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 174(2): 353-359.
26. Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A, (2003) Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrin Metab 88(11): 5361-5365.
27. Díaz E, Cárdenas M, Ariza AC, Larrea F, Halhali A, (2005) Placental insulin and insulin-like growth factor I receptors in normal and preeclamptic pregnancies. Clin Biochem 38(3): 243-247.
28. Ming Fang, Zhou Rong, Cheng Weibo, Tie Weiwei, (2008) Study of adiponectin expression in placenta and its correlation with preeclampsia. Chin J Obstet Gynecol 43(2): 90-93.